The notices it replaced
- Reissues: PA-15-269 PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 2 steps back: PA-14-071 PHS 2014-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 3 steps back: PA-13-234 Reissue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 4 steps back: PA-13-088 PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 5 steps back: PA-12-088 PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 6 steps back: PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 7 steps back: PA-10-050 PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 8 steps back: PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Replaced by PA-17-302.
Who won it before
2,800 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $993,526,938 in first-year total cost, median $225,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-G (12)]161
- Special Emphasis Panel[ZRG1 SBIB-T (10)]134
- Special Emphasis Panel[ZRG1 ETTN-M (11)]124
- Special Emphasis Panel[ZRG1 RPHB-C (10)]115
- Special Emphasis Panel[ZRG1 IDM-V (12)]106
Most frequent institutions
- PANORAMA RESEARCH, INC.21
- AFFINERGY, LLC18
- PHYSICAL SCIENCES, INC17
- PROGENRA, INC.17
- 3-C INSTITUTE FOR SOCIAL DEVELOPMENT13
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information2R44HG008118-04A1 | DIXON, JESSE RLAURENT, LOUISE CHANGSELVARAJ, SIDDARTH | ARIMA GENOMICS, INC., CA | $1,573,140 | ZRG1 |
| 2018 | Small Molecule Treatments to Enhance Neurological Recovery After Stroke2R44NS095381-02 | FINKLESTEIN, SETH P | STEMETIX, INC., MA | $1,354,461 | ZRG1 |
| 2018 | Development of a Yellow Fever Vaccine for a Vulnerable Population2R44AI079898-06 | AMANNA, IAN JAMESSLIFKA, MARK K | NAJIT TECHNOLOGIES, INC., OR | $1,248,114 | ZRG1 |
| 2018 | Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women2R44AG046005-02 | BILEK, LAURA DIANEBURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $1,146,609 | ZRG1 |
| 2018 | Device for rapid extraction of rare pathogens from raw samples2R44AI124930-02 | FISHER, JAY KENNETH | REDBUD LABS, INC., NC | $1,140,832 | ZRG1 |
| 2018 | A Novel Test to Measure Latent Virus in HIV-1 Infected Patients2R44AI124996-02 | LAIRD, GREGORY MICHAEL | ACCELEVIR DIAGNOSTICS, LLC, MD | $1,000,000 | ZRG1 |
| 2018 | Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries2R44AI124933-03 | CARPENTER, MEREDITH LAUREN | ARC BIO, LLC, MA | $998,921 | ZRG1 |
| 2018 | Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine2R44AI114331-02A1 | BAGLEY, KENNETH C | PROFECTUS BIOSCIENCES, INC., MD | $993,161 | ZRG1 |
| 2018 | Evaluating the impact of novel inhibitors of nuclear pore export in SLE2R44AI124949-02 | LANDESMAN, YOSEFTAMIR, SHARON | KARYOPHARM THERAPEUTICS, INC., MA | $992,511 | ZRG1 |
| 2018 | Development of Molecular Diagnostic Test for Early Onset of Lyme disease2R44AI114009-02 | SCHUTZER, STEVEN E | BIOSCIENCE DEVELOPMENT, INC., NY | $988,413 | ZRG1 |
| 2018 | Aerosol Delivery of Surfactant for ARDS2R44HL127834-02A1 | YEATES, DONOVAN BYRON | KAER BIOTHERAPEUTICS CORPORATION, CA | $986,436 | ZRG1 |
| 2018 | Multiplexed Bead-based In Vitro Pediatric Allergy Test2R44AI100424-06 | LIM, MARK | AMBERGEN, INC, MA | $937,987 | ZRG1 |
| 2018 | High-throughput methyltransferase assays using recombinant nucleosome substrates2R44GM117683-02A1 | SUN, ZU-WEN | EPICYPHER, INC., NC | $903,808 | ZRG1 |
| 2018 | Development of a novel highly effective influenza vaccine2R44AI109925-03 | BILSEL, PAMUKSARAWAR, SALLY R. | FLUGEN, INC., WI | $834,285 | ZRG1 |
| 2018 | Miniaturized Stopped-Flow Reaction Microcalorimeter for Biomedical Applications2R44GM113279-02A1 | BROWN, RICHARD KENNETH | CAPE BIORESEARCH, INC., MA | $775,488 | ZRG1 |
| 2018 | Over-the-Wire Device for Immediate and Complete Peripheral Artery Occlusion2R44HL124832-02A1 | FRANANO, F. NICHOLAS | ARTIO MEDICAL, INC., KS | $765,897 | ZRG1 |
| 2018 | Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection2R44EY026850-02A1 | YANG, ARTHUR | LYNTHERA CORPORATION, PA | $754,785 | ZRG1 |
| 2018 | Wireless Sensor Inserts for Combating Incontinence-Associated Dermatitis2R44NR014614-02A1 | PROKOPUK, NICHOLAS | JPTECHNOLOGIES, INC., CA | $750,000 | ZRG1 |
| 2018 | The Variant Explorer: a cloud-based data integration and visualization system for improving clinical interpretation of sequenced genetic variants.2R44GM117644-02 | XU, XING | SOLVE, INC., NY | $748,556 | ZRG1 |
| 2018 | Comprehensive but simple encoding of bioassays to accelerate translational drug discovery2R44TR000185-04A1 | BUNIN, BARRY A | COLLABORATIVE DRUG DISCOVERY, INC., CA | $744,321 | ZRG1 |
| 2018 | Tools for drug efficacy studies in perfused tissue models2R44TR001286-02 | VUKASINOVIC, JELENA | LENA BIOSCIENCES, INC., GA | $724,224 | ZRG1 |
| 2018 | Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause1R43AG056209-01A1 | DUKE, RICHARD C | MENOGENIX, INC., CO | $693,360 | ZRG1 |
| 2018 | miR-SEQ: Highly efficient targeted quantification of extracellular miRNAs by Next Generation Sequencing2R44GM115124-03 | BARBERAN-SOLER, SERGIO | SOMAGENICS, INC., CA | $623,228 | ZRG1 |
| 2018 | Clinical optical coherence tomography for retinal metabolic imaging2R44EY026466-02 | KURANOV, ROMAN | OPTICENT, INC., IL | $617,592 | ZRG1 |
| 2018 | Rapid response toxicology prediction platform2R44ES026909-02 | MYATT, GLENN JOHN | LEADSCOPE, INC., OH | $612,360 | ZRG1 |
| 2018 | CFI Pathogen Inactivation of Human Plasma Units1R44HL137605-01A1 | CASTOR, TREVOR P.OCHIENG, WASHINGTONE | APHIOS CORPORATION, MA | $599,617 | ZRG1 |
| 2018 | Low-temperataure plasma decontamination of pharmaceutical manufacturing fill/finish operations2R44TR001847-02 | GALBALLY-KINNEY, KRISTIN L | PHYSICAL SCIENCES, INC, MA | $583,124 | ZRG1 |
| 2018 | Improving Patient Outcomes through Tracking and Displaying the Disinfection Status of Equipment and Area2R44NR016638-02 | STIBICH, MARK A | XENEX DISINFECTION SERVICES, LLC, TX | $564,057 | ZRG1 |
| 2018 | New Technology to Improve Chemotherapy Safety for Cancer Patients and Health Workers1R43CA224598-01 | SUNKARA, PRASAD | J AND J SOLUTIONS, INC., IA | $548,377 | ZRG1 |
| 2018 | A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules2R44CA203058-02A1 | MENG, XIN | INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB, PA | $529,613 | ZRG1 |
| 2018 | Multi-modal AO-LSO Phase Gradient Imaging of the Inner Retina2R44EY023481-02 | FERGUSON, R DANIEL | PHYSICAL SCIENCES, INC, MA | $527,107 | ZRG1 |
| 2018 | Use of DNATrax and high fidelity computational methods to model transport of contaminants in urban environments2R44ES025070-02 | ZOGRAFOS, ANTONIOS | SAFETRACES, INC., CA | $523,978 | ZRG1 |
| 2018 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms2R44GM119906-02 | LOCKERY, SHAWN RMCCORMICK, KATHRYN EROBERTS, WILLIAM MWEEKS, JANIS C | NEMAMETRIX, INC., OR | $510,448 | ZRG1 |
| 2018 | Confocal and Autofluorescence Imaging of Macular Degeneration using a Low Cost Digital Imager2R44EY024186-02A1 | MULLER, MATTHEW S | AEON IMAGING, LLC, IN | $505,350 | ZRG1 |
| 2018 | Improving drug safety for pregnant women by delivering current and authoritative information via mobile devices2R44DD001127-02 | MARKHAM, GLEN | RIGHTANSWER.COM, INC., MI | $499,961 | ZRG1 |
| 2018 | Development and validation of a novel non-invasive device for measuring the mechanical properties of cortical bone1R43AG058312-01 | CLARK, BRIAN CDICK, ANDREWLOUCKS, ANNE B | OSTEODX INC., OH | $477,486 | ZRG1 |
| 2018 | A Computer Model of Renal Physiology for use as a FDA Medical Device Development Tool2R44FD005669-02 | PRUETT, WILLIAM ANDREW | HC SIMULATION, LLC, MS | $441,039 | ZRG1 |
| 2018 | PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD1R44NS105156-01 | ALWORTH, SAMUEL VZHOU, HONGYAN | ACURASTEM, INC., CA | $433,105 | ZRG1 |
| 2018 | Development of an Anti-Embolic Micromesh Carotid Stent1R43HL140895-01 | KEALEY, COLIN PATRICK | NEUROSIGMA, INC., CA | $415,743 | ZRG1 |
| 2018 | Preclinical Testing of Splice Modulating Oligonucleotides Targeting SCN8A to Treat Dravet Syndrome1R43NS105291-01 | TALLENT, MELANIE K | LIFESPLICE PHARMA, LLC, PA | $389,793 | ZRG1 |
| 2018 | Development of an Autism Spectrum Disorder Screening Test based upon Metabolic Profiling of Fresh Blood Samples1R41MH115642-01 | CHAMPAIGNE, KEVIN D | CIRCA BIOSCIENCE, LLC, SC | $371,711 | ZRG1 |
| 2018 | A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Pterygium Patients1R44EY028784-01 | NI, JINSONG | CLOUDBREAK THERAPEUTICS, LLC, CA | $326,960 | ZRG1 |
| 2018 | PLGA encapsulated polyphenols to ameliorate IBD.1R43AT009800-01 | AUCI, DOMINICKDRYDEN, GERALD W | THERAPYX, INC., NY | $320,159 | ZRG1 |
| 2018 | Remodeled glycoprotein for broad protection against ebolaviruses1R43AI136229-01 | AMAN, M JAVAD | INTEGRATED BIOTHERAPEUTICS, INC., MD | $302,469 | ZRG1 |
| 2018 | Aptamer Beacons For High-Throughput Assay Development1R43GM126724-01 | KEOGH, MICHAEL-CHRISTOPHER | EPICYPHER, INC., NC | $300,244 | ZRG1 |
| 2018 | Culture-free identification of pathogens common in endocarditis directly from patient specimens1R43AI136064-01 | SINGER, ALON | HELIXBIND, INC., MA | $300,000 | ZRG1 |
| 2018 | UroLogic: Rapid, Near-to-Care Identification and Antimicrobial Susceptibility Testing of Microbes in Urine Specimens from Outpatients with Suspected Urinary Tract Infection1R43AI127015-01A1 | CHURCHILL, BERNARD M | MICROBEDX, INC., CA | $300,000 | ZRG1 |
| 2018 | Cpf1-mediated inactivation of an AAV transgene1R43AI136163-01 | ALPERT, MICHAEL DAVIDZHONG, GUOCAI | EMMUNE, INC, FL | $300,000 | ZRG1 |
| 2018 | Development of highly potent human monoclonals for RSV immunoprophylaxis1R43AI136272-01 | ZEITLIN, LARRY | MAPP BIOPHARMACEUTICAL, INC., CA | $300,000 | ZRG1 |
| 2018 | Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care1R43AI136161-01 | PAIS, ANDREA | NOVEL MICRODEVICES, LLC, MD | $300,000 | ZRG1 |
| 2018 | Point of care assay for serodiagnosis of Leptospirosis1R43AI136551-01 | GOMES-SOLECKI, MARIA | IMMUNO TECHNOLOGIES, INC., TN | $300,000 | ZRG1 |
| 2018 | Development, GMP manufacture, and quality control release of a triple knock out genetically attenuated Plasmodium falciparum sporozoite vaccine1R43AI136219-01 | HOFFMAN, STEPHEN LEV | SANARIA, INC., MD | $299,999 | ZRG1 |
| 2018 | Point-of-care diagnostic test for T. cruzi (Chagas) infection1R43AI136172-01 | LEVIN, ANDREW E. | KEPHERA DIAGNOSTICS, LLC, MA | $299,999 | ZRG1 |
| 2018 | Restoring Beta-lactam efficacy against methicillin-resistant Staphylococci1R44AI136213-01 | ROEMER, TERRY | PROKARYOTICS, INC., NJ | $299,999 | ZRG1 |
| 2018 | Humanized Anti-Renalase Antibodies for Unresectable Melanoma1R43CA224463-01 | BERKOWITZ, BARRY ADESIR, GARY V.KLUGER, HARRIET M. | BESSOR PHARMA, LLC, MA | $299,996 | ZRG1 |
| 2018 | An antigen-detection assay to diagnose Babesia microti infection1R43AI136118-01 | LEDIZET, MICHEL | L2 DIAGNOSTICS, LLC, CT | $299,975 | ZRG1 |
| 2018 | A Noninvasive Prenatal Testing Platform for Aneuploidy at Five Weeks of Gestation1R43HD094405-01 | ARMANT, DAVID RANDALLDREWLO, SASCHAKADAM, LEENAKOHAN-GHADR, HAMID-REZA | CRADLE GENOMICS, INC., CA | $299,969 | ZRG1 |
| 2018 | BT-11: A First-in-class Oral Therapeutic for Inflammatory Bowel Disease1R44AI134163-01A1 | BASSAGANYA-RIERA, JOSEP | BIOTHERAPEUTICS, INC., VA | $299,576 | ZRG1 |
| 2018 | Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay1R43AI136197-01 | CAMERINI, DAVID | IMMPORT THERAPEUTICS, INC., CA | $299,564 | ZRG1 |
| 2018 | Inhibitors of virus glycoprotein-LAMP1 receptor binding for Lassa virus therapy1R43AI136188-01 | LIU, GAI | MICROBIOTIX, INC, MA | $299,400 | ZRG1 |
| 2018 | Targeting Exonuclease Resistant RNA to Develop Zika Virus Therapeutics1R43AI136190-01 | KIMSEY, ISAAC J | NYMIRUM, INC., MI | $299,236 | ZRG1 |
| 2018 | Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines1R44AI136236-01 | WANG, JOSHUA WEIYUAN | PATHOVAX, LLC, MD | $299,068 | ZRG1 |
| 2018 | FAST platform for same-shift, complete antibiotic menu antibiotic susceptibility testing1R43AI136125-01 | STERN, ERIC | SELUX DIAGNOSTICS, INC., MA | $298,851 | ZRG1 |
| 2018 | Robust Small Animal Oxygen Imager to Model Enhanced Cancer Treatment1R43CA224840-01 | EPEL, BORISKOTECHA, MRIGNAYANI | O2M TECHNOLOGIES, LLC, IL | $298,245 | ZRG1 |
| 2018 | Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension1R44HL140690-01 | LEE, JOHN | PHASEBIO PHARMACEUTICALS, INC., PA | $297,765 | ZRG1 |
| 2018 | Real-Time Salivary Testosterone and Extension to Mobile Application and Multiple Biomarker Quantification Capability1R43DA043293-01A1 | SLOWEY, PAUL DESMOND | OASIS DIAGNOSTICS CORPORATION, WA | $294,373 | ZRG1 |
| 2018 | Device for rapid, on-chip, sample-to-answer bacterial identification and drug susceptibility testing1R43AI136461-01 | FISHER, JAY KENNETH | REDBUD LABS, INC., NC | $294,357 | ZRG1 |
| 2018 | Form factor determination for the Talon microIPG system to treat Chronic Migraine1R43NS102302-01A1 | DULAK, GARYHOFFMANN, DREW | NEOGENESIS TECHNOLOGIES, LLC, CA | $287,154 | ZRG1 |
| 2018 | Nonsense Suppressing Drugs for Rett Syndrome1R43NS100227-01A1 | KOZIKOWSKI, ALAN P. | STARWISE THERAPEUTICS, LLC, IL | $282,726 | ZRG1 |
| 2018 | Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy1R43CA224602-01A1 | BHATTA, MAULASRI | IMMUNE MODULATORY THERAPIES, LLC, NY | $280,928 | ZRG1 |
| 2018 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN1R43DA045410-01 | RIVIERE, PIERRE | PEPTIDE LOGIC, LLC, CA | $279,411 | ZRG1 |
| 2018 | Preclinical small animal imaging platform for detection and quantification of early metastasis1R43CA224824-01 | ERMILOV, SERGEY A | PHOTOSOUND TECHNOLOGIES, INC., TX | $279,143 | ZRG1 |
| 2018 | A Novel Inhibitor of the Classical Pathway of Complement1R43HL140716-01 | OLIVO, PAUL DAVID | ANTHROBIO, INC., MO | $254,235 | ZRG1 |
| 2018 | Preclinical development of an intravaginal ring for the sustained release of Pritelivir for the treatment and prophylaxis of Genital Herpes in women1R43AI136201-01 | SMITH, THOMAS J. | AURITEC PHARMACEUTICALS, INC., CA | $251,190 | ZRG1 |
| 2018 | Demonstrating Utility of a Non-Infectious Minute Virus of Mice-Virus Like Particle for Predicting Viral Clearance during Biopharmaceutical Process Development1R43TR002231-01A1 | CETLIN, DAVID | MOCKV SOLUTIONS, INC, MD | $250,000 | ZRG1 |
| 2018 | Identification of lead chemical scaffolds targeting opioid receptor heteromers.1R43DA045411-01 | YEKKIRALA, AJAY S | BLUE THERAPEUTICS, INC., MA | $249,685 | ZRG1 |
| 2018 | Middle-ear reflex testing using WAI1R43DC016780-01 | HOOD, LINDA J.JENG, PATRICIA S | MIMOSA ACOUSTICS, IL | $245,733 | ZRG1 |
| 2018 | Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia1R43MH114765-01A1 | BIAGIANTI, BRUNO | POSIT SCIENCE CORPORATION, CA | $245,571 | ZRG1 |
| 2018 | Less is More: Context-relevant views of EHRs1R43AG058357-01 | BOXWALA, AZIZ A | ELIMU INFORMATICS, INC., CA | $243,998 | ZRG1 |
| 2018 | Preparation and development of a stabilized C3 analog for the treatment of paroxysmal nocturnal hemoglobinemia1R43HL139170-01A1 | FRITZINGER, DAVID CHARLES | CASCADE BIOTECHNOLOGY, INC., NJ | $240,748 | ZRG1 |
| 2018 | Tortuous vascular accessibility with a novel coaxial active deflectable microcatheter1R44HL137521-01A1 | TULLY, STEPHEN | AGILE DEVICES, INC., MA | $233,642 | ZRG1 |
| 2018 | Antimicrobial Intravascular Catheter Lock Solutions Based on Endogenous Nitric Oxide Release Agent1R43AI136182-01 | MARTIN, GLENN | NOTA LABORATORIES, LLC, MI | $233,275 | ZRG1 |
| 2018 | Development of an oral drug targeting SUMOylation1R43CA217349-01A1 | CEE, VICTOR | SUVALENT THERAPEUTICS, INC., CA | $232,759 | ZRG1 |
| 2018 | Preclinical development of Novo29, a new antibiotic1R43AI136137-01 | LING, LOSEE LUCY | NOVOBIOTIC PHARMACEUTICALS, LLC, MA | $231,409 | ZRG1 |
| 2018 | A Rapid, Near Patient System for Small Blood Volume Testing of Ammonia, Glutamine and Glutamate to Support Recurrent Monitoring of Acute Neonatal Hyperammonemia1R43HD094507-01 | SINGH, RAJENDRA | BAEBIES, INC., NC | $231,134 | ZRG1 |
| 2018 | VR Grip Hand Peripheral for Improved Resident Training in Surgical Simulations1R43GM126719-01 | MARTIN, MICHAEL WILLIAM | LYNNTECH, INC., TX | $230,987 | ZRG1 |
| 2018 | Next Generation All Solid State NASS Lithium Batteries for Implantable Devices1R43HL140891-01 | LI, XUGUANG | LYNNTECH, INC., TX | $228,773 | ZRG1 |
| 2018 | Pan-HIV Incidence Assay Development1R43AI136196-01 | CAMERINI, DAVID | IMMPORT THERAPEUTICS, INC., CA | $225,707 | ZRG1 |
| 2018 | Rapid Baseline Free Organophosphate Exposure Diagnostic Test1R43NS102080-01A1 | BASINGER, BILL | COUNTERVAIL CORPORATION, NC | $225,225 | ZRG1 |
| 2018 | New Biotechnology using MicroRNA Inhibitors to Regenerate Alveolar Bone1R43DE027569-01 | SANDRA, ALEXANDER | NATUREMIRI, LLC, IA | $225,000 | ZRG1 |
| 2018 | An Acoustofluidic Device for Biocompatible Platelet Separation1R43HL140800-01 | WANG, LIN | ASCENT BIO-NANO TECHNOLOGIES, INC., NC | $225,000 | ZRG1 |
| 2018 | Development of an alpha-conotoxin RgIA analog as a novel, non-opioid therapeutic for chronic neuropathic pain1R43DA045413-01 | MERCADO, JOSE L | KINETA, INC., WA | $225,000 | ZRG1 |
| 2018 | A novel nutraceutical drug for tendinopathy treatment1R43AT009414-01A1 | LEONG, DANIEL JSUN, HUI BIN | NEW YORK/R&D/CTR/TRANSLATIONAL MED/THER, NY | $225,000 | ZRG1 |
| 2018 | Activating latent growth factors for cartilage regeneration1R43AG058311-01 | LIU, YONGXING "JAMES" | INNOVATIVE ELEMENTS, LLC, NJ | $225,000 | ZRG1 |
| 2018 | A wearable device to detect opioid overdose and to prevent death1R43DA045407-01 | FARID-MOAYER, MEHRAN | BIORESP TECHNOLOGIES, INC., CA | $225,000 | ZRG1 |
| 2018 | Universal Influenza Vaccine1R43AI136291-01 | LOCHER, CHRISTOPHER | VERSATOPE THERAPEUTICS, INC., MA | $225,000 | ZRG1 |
| 2018 | High-definition, wide field of view corneal imaging1R43EY028827-01 | CANAVESI, CRISTINA | LIGHTOPTECH CORPORATION, NY | $225,000 | ZRG1 |
| 2018 | A high throughput next generation sequencing (NGS) pipeline to generate high quality recombinant therapeutic antibodies1R43CA224843-01 | BRADBURY, ANDREW | SPECIFICA, INC., NM | $225,000 | ZRG1 |
| 2018 | Off-the-Shelf Patch for Repairing Tracheal Stenosis1R43HL140890-01 | JOHNSON, JED KIZER | NANOFIBER SOLUTIONS, LLC, OH | $225,000 | ZRG1 |
| 2018 | High Density Array Digital PCR for Cancer Rare Mutation Quantification1R43CA221597-01A1 | HUNG, PAUL JU-SUNG | COMBINATI, INC., CA | $225,000 | ZRG1 |
| 2018 | Development of a cell based assay to assess antigen specific tolerance1R43AI136484-01 | BERRY, SCOTT MMULLINS, BRIANNA | SALUS DISCOVERY, LLC, WI | $225,000 | ZRG1 |
| 2018 | Real-time monitoring of inorganic chloramines near swimming pools1R43CK000544-01 | COWART, JOHN | SEACOAST SCIENCE, INC., CA | $225,000 | ZRG1 |
| 2018 | HeartMapp: A Closed-Loop Assessment and Treatment Mobile Application for Heart Failure1R43NR018415-01 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $225,000 | ZRG1 |
| 2018 | A Sensor-based Platform for Hand Hygiene Tracking and Analysis1R43NR017372-01A1 | LIU, PENG PAUL | MICROSENSOR LABS, LLC, IL | $225,000 | ZRG1 |
| 2018 | Exploiting activation-induced cell death as a means of inducing tolerance to kidney allografts1R43AI136151-01 | REDFIELD, ROBERT RAYYOLCU, ESMA S | FASCURE THERAPEUTICS, LLC, KY | $224,999 | ZRG1 |
| 2018 | Novel Immunotherapies for Comorbidity of Clostridium difficile and Inflammatory Bowel Disease1R43AI136108-01 | YANG, ZHIYONG | FZATA, INC., MD | $224,999 | ZRG1 |
| 2018 | Development of a hybrid transcatheter mitral valve replacement and repair device1R44HL140835-01 | PHAM, THUY M | SUTRA MEDICAL, INC., CA | $224,997 | ZRG1 |
| 2018 | A system to detect fall occurrence and location in hospital settings1R43AG056224-01 | CLARK, BRIAN RPARKER, B EUGENE | BARRON ASSOCIATES, INC., VA | $224,994 | ZRG1 |
| 2018 | Fast, flexible, and economical system for affinity-tag protein purification and tag removal1R43GM126676-01 | BRYAN, PHILIP N | POTOMAC AFFINITY PROTEINS, LLC, MD | $224,994 | ZRG1 |
| 2018 | Scriptmate: A patient-centered mobile system for geriatric prescription medication management1R43AG057319-01 | HO, Y. XIANJACKSON, JONATHAN LEE | DIMAGI, INC., MA | $224,991 | ZRG1 |
| 2018 | Novel therapy for atopic dermatitis1R43AI136181-01 | LARRICK, JAMES WYU, BO | LARIX BIOSCIENCE, LLC, CA | $224,981 | ZRG1 |
| 2018 | Cerberus therapy for metastatic disease1R43CA217408-01A1 | MARTINEZ HACKERT, ERIK MATTHIASMESSMER, DAVORKA | TALAPO THERAPEUTICS, INC., CA | $224,980 | ZRG1 |
| 2018 | Development of a unified information-rich test for CNBP and DMPK to improve assessment of Myotonic Dystrophy Type 1 and 21R43NS105463-01 | HALL, BRADLEY | ASURAGEN, INC., TX | $224,978 | ZRG1 |
| 2018 | Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine1R43NS102088-01A1 | LEBAKKEN, CONNIE S | STEM PHARM, INC., WI | $224,976 | ZRG1 |
| 2018 | mHealth for Patient Self-Management of Opioid Use Disorder1R43MH119672-01 | BOWDEN, CHARLES LEE | BIOMEDICAL DEVELOPMENT CORPORATION, KY | $224,959 | ZRG1 |
| 2018 | Automatic Phrenic Nerve Stimulation to Rescue Opioid Induced Respiratory Depression1R43DA045442-01 | LEVIN, HOWARD D | CORIDEA, LLC, NY | $224,959 | ZRG1 |
| 2018 | Improved RSV F Vaccine Candidates1R43AI122411-01A1 | TOBIN, GREGORY JOHN | BIOLOGICAL MIMETICS, INC., MD | $224,956 | ZRG1 |
| 2018 | Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease1R43GM126828-01 | XU, KAREN D. | PRIMROSE BIO, INC., CA | $224,952 | ZRG1 |
| 2018 | HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform1R43HL140920-01 | HICKMAN, JAMES JSHULER, MICHAEL L | HESPEROS, LLC, FL | $224,946 | ZRG1 |
| 2018 | 3D Imaging Flow Cytometer1R43DA045460-01 | CHO, SUNG HWANLO, YU-HWA | NANOCELLECT BIOMEDICAL, INC., CA | $224,935 | ZRG1 |
| 2018 | Rapid and Efficient Extraction of Bacteria from Whole Blood for Sepsis Diagnosis1R43AI132072-01A1 | GATES, ELISABETH | PRECISION MEMBRANES, LLC, UT | $224,925 | ZRG1 |
| 2018 | Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection1R44HL140662-01 | PAMULA, VAMSEE K. | BAEBIES, INC., NC | $224,903 | ZRG1 |
| 2018 | A Resonator for Pulsed ODNP Spectroscopy to Study Surface Hydration Dynamics1R43GM126770-01 | MALY, THORSTEN | BRIDGE 12 TECHNOLOGIES, INC., MA | $224,889 | ZRG1 |
| 2018 | Online course to prepare promotores to support low-income Latino parents of children with special healthcare needs1R44MD012412-01 | TWOMBLY, ERIC CHARLES | KDH RESEARCH AND COMMUNICATION, INC., GA | $224,828 | ZRG1 |
| 2018 | Device for Rapid, Complete & Durable Occlusion of Wide-Neck Cerebral Aneurysms1R43NS092184-01A1 | FRANANO, F. NICHOLASLOREE, HOWARD MARTIN | ARTIO MEDICAL, INC., KS | $224,818 | ZRG1 |
| 2018 | A Sensitive and Selective Microfluidic Nitrite Sensor1R43GM126768-01 | MCDUNN, JONATHAN EDWARD | CLINICAL SENSORS, INC., NC | $224,805 | ZRG1 |
| 2018 | The Home Evaluation, Assessment, Rating and Training of Gait (HEART-Gait) System for Monitoring Toe-Walking Severity in Children with Cerebral Palsy1R43LM013104-01 | BAMBERG, STACY J. MORRIS | VERISTRIDE, INC., UT | $224,740 | ZRG1 |
| 2018 | Development of Non-Stigmatizing Hip Protection for Prevention of Fall-Related Injuries1R43AG054265-01A1 | CACCESE, VINCENTCASTLE, STEVENFERGUSON, JAMES RIDDELL | ALBA-TECHNIC, LLC, ME | $224,682 | ZRG1 |
| 2018 | Neural Modulation System for In-Home Treatment of Overactive Bladder1R43AG058272-01 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $224,534 | ZRG1 |
| 2018 | Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis1R44HL140735-01 | HEIFETZ, PETER B | ORPRO THERAPEUTICS, INC., CA | $224,482 | ZRG1 |
| 2018 | Mulitplexed detector array for VOC biomarker development1R43ES029032-01 | SAVOY, STEVE MICHAEL | NANOHMICS, INC., TX | $224,325 | ZRG1 |
| 2018 | io-Balance assessment of balance control and fall risk1R43AG057281-01 | REEVES, NORMAN PETER | SUMAQ LIFE, LLC, MI | $224,132 | ZRG1 |
| 2018 | HEART: Adding Memory to Reasoning: macHine lEArning tailoRed drug Titration1R43HL140624-01 | VOSKERICIAN, GABRIELA | OPTIMA INTEGRATED HEALTH, INC., CA | $224,090 | ZRG1 |
| 2018 | Oxygen-Generating Dressing1R43NR017127-01A1 | CARTER, ANDY | THERACELL, INC., CA | $223,730 | ZRG1 |
| 2018 | FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis1R43GM126617-01 | WEINBERGER, SCOT RANDY | GENNEXT TECHNOLOGIES, INC., CA | $223,704 | ZRG1 |
| 2018 | Using Augmented Reality To Make Cardiac Ablation Procedures Simpler and Safer1R44HL140896-01 | BLUME, WALTERSILVA, JENNIFER NSILVA, JONATHAN R | SENTIAR, INC., MO | $223,532 | ZRG1 |
| 2018 | Omniphobic Coating to Prevent Central Line Catheter Infections1R43AI136573-01 | JONES, ANDREW K | CERULEAN SCIENTIFIC INC., PA | $222,842 | ZRG1 |
| 2018 | Head mounted smartphone system for remote treatment of convergence insufficiency1R43EY028778-01 | HOUSTON, KEVIN EDWARDLUO, GANGTOMASI, MATTEO | EYENEXO LLC, MA | $219,444 | ZRG1 |
| 2018 | Enhanced x-ray angiography analysis and interpretation using deep learning1R43HL140794-01 | HENAO GIRALDO, RICARDOPATEL, MANESH RVENKATESHA, SANTOSH | VIGILANT MEDICAL, INC., MD | $217,746 | ZRG1 |
| 2018 | GreenCare Interactive Guide for Knee Replacement Surgery1R43AG055219-01A1 | MIRZA, SOHAIL K | PEER TECHNOLOGIES, PLLC, DC | $217,597 | ZRG1 |
| 2018 | Feasibility and validation of an integrated newborn screening algorithm with the targeted Next Generation Sequencing (tNGS) technology as part of a 2nd tier test for Pompe and MPS I1R43HD094543-01 | BHATTACHARJEE, ARINDAM | BAEBIES, INC., NC | $215,022 | ZRG1 |
| 2018 | SiPM Array detector for 50 ps CTR1R43MH115637-01 | HARMON, ERIC S | LIGHTSPIN TECHNOLOGIES, INC., NY | $213,938 | ZRG1 |
| 2018 | Prehospital and Emergency Room Stroke Diagnosis Using Quantitative Cerebral Hemodynamics1R43NS105340-01 | THIBEAULT, COREY MICHAEL | NEURAL ANALYTICS, INC., CA | $213,206 | ZRG1 |
| 2018 | Minimizing bloodstream infection detection time using laser light-scattering1R43AI136184-01 | TOMARAS, ANDREW P | BACTERIOSCAN, INC., MO | $210,937 | ZRG1 |
| 2018 | Adaptive Web-based Software for Enhancing Social Communication Skills in Youth with Autism Spectrum Disorder to Facilitate Employment Success1R43DC016769-01 | CHILDRESS, DEBRA | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $209,696 | ZRG1 |
| 2018 | A Tailored Approach to Promoting Engagement in Public Health1R44NR016908-01A1 | HIRSHFIELD, SABINATAN, WILLIAM Z | TRANSCENDENT INTERNATIONAL, LLC, NY | $207,995 | ZRG1 |
| 2018 | Calpain Therapeutics to Inhibit Myofibroblast Generation in Fibrosis1R43HL140829-01 | GREENBAUM, DORON | PHELIX THERAPEUTICS, LLC, PA | $201,665 | ZRG1 |
| 2018 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents1R43GM126604-01 | YANG, XIANBIN | AM BIOTECHNOLOGIES, LLC, TX | $185,564 | ZRG1 |
| 2018 | Next Generation Testing Strategies for Assessment of Genotoxicity1R44ES029014-01 | BEMIS, JEFFREY CDERTINGER, STEPHEN D | LITRON LABORATORIES, LTD., NY | $178,854 | ZRG1 |
| 2018 | Rapid automated polarizable multipole-based force field parameterization for accurate drug-receptor binding affinity calculations.1R43GM126579-01 | HO, CHRIS M | DRUG DESIGN METHODOLOGIES, LLC, MO | $175,994 | ZRG1 |
| 2018 | Validation of Cross-Species Biomarkers of DNA Damage1R44ES028163-01A1 | BEMIS, JEFFREY CDERTINGER, STEPHEN D | LITRON LABORATORIES, LTD., NY | $172,660 | ZRG1 |
| 2018 | A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridium difficile Infection1R43AI136176-01 | YANG, ZHIYONG | FZATA, INC., MD | $168,931 | ZRG1 |
| 2018 | A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells1R43HG010025-01 | MCCONNELL, TIMOTHY SZHENG, RUI | ISOPLEXIS, INC., DE | $163,731 | ZRG1 |
| 2018 | A Customizable Real-Time Biosensor for Continuous Monitoring of Water Contaminants1R43ES028993-01 | COOKSON, SCOTT WARREN | QUANTITATIVE BIOSCIENCES, INC., CA | $162,205 | ZRG1 |
| 2018 | Multifunctional Antioxidant to Prevent Noise-Induced Hearing Loss1R43DC016766-01 | KADOR, PETER F | THERAPEUTIC VISION, INC., NE | $150,000 | ZRG1 |
| 2018 | RECAL®: A New Tool for Disease Detection and Biomolecular Imaging1R43GM126577-01 | BORDERS, BRYAN CLARKE | PHOTON BIOSCIENCES, LLC, WA | $150,000 | ZRG1 |
| 2018 | HLS- SBIR Phase I: Development of a robust, color-based, disposable, standalone anemia test for low-resource settings1R43HL139250-01A1 | LAM, WILBUR ASTRIBLING, THOMAS SLIGH | SANGUINA, LLC, GA | $150,000 | ZRG1 |
| 2018 | Miniaturized Global Coagulation Assay System in Neonatal and Pediatric Settings1R43HL140686-01 | KOLANDAIVELU, KUMARANZHAO, XIN | ATANTARES CORPORATION, MA | $150,000 | ZRG1 |
| 2018 | New Techniques for Real-Time Microsleep Assessment1R43DP006416-01 | LANDAU, ALEXANDER | VERIFAX CORPORATION, CO | $150,000 | ZRG1 |
| 2018 | Polyketide chiral building blocks and biocatalysts1R43GM126594-01 | GAY, DARREN CHRISTIANKEATINGE-CLAY, ADRIAN TRISTAN | COALA BIOSCIENCES, TX | $149,999 | ZRG1 |
| 2018 | Development of a Human Liver Microphysiological System For Alcoholic Liver Disease1R43AA026473-01 | BARREIROS PETROPOLIS, DEBORAKARALIS, KATIA | EMULATE, INC., MA | $149,996 | ZRG1 |
| 2018 | Medical Device Cyber-Security1R43GM126614-01 | UPLINGER, JAMES | NOKOMIS, INC., PA | $149,782 | ZRG1 |
| 2018 | Deep Learning to Transform Clinician Autism Diagnostic Assessments and More1R44MH115523-01 | OBERLEITNER, RONALD | CARING TECHNOLOGIES, INC., ID | $149,124 | ZRG1 |
| 2018 | In situ assay for RNA decapping in tumors1R43CA221560-01 | WANG, SHA | VIVID TECHNOLOGIES, TX | $149,051 | ZRG1 |
| 2018 | An integrated mobile and web-based application for problem cannabis use1R43DA045390-01 | CAMPBELL, WILLIAM P | CHECKUP AND CHOICES, LLC, NM | $148,980 | ZRG1 |
| 2018 | Integrated System for Rapid Production of Activated Sugars and Glycosylated Molecules1R43GM126672-01 | AMINOVA, LEILA | ZUCHEM, INC., IL | $147,325 | ZRG1 |
| 2018 | A Low-Cost Platform for Routine High-Accuracy Sizing of Nucleic Acid Samples with 100 bp - 100 Mbp Dynamic Range1R44HG009993-01 | MENARD, LAURENT | GENTURI, INC., MA | $146,126 | ZRG1 |
| 2018 | Development of a syringe/sonication device employed to administer DDFPe in the prehospital setting1R43NS105295-01 | UNGER, EVAN CHARLES | NUVOX PHARMA, LLC, AZ | $143,988 | ZRG1 |
| 2018 | Powerful Solid-State Sources to Enable Advanced EPR and DNP-NMR Measurements1R43GM126771-01 | BRYERTON, ERIC | VIRGINIA DIODES, INC., VA | $138,047 | ZRG1 |
| 2018 | Universal Liquid Chromatography Detector Utilizing Reactive Flame Ionization Detection1R43GM126591-01 | JONES, ANDREW JAMES | ACTIVATED RESEARCH COMPANY, LLC, MN | $78,518 | ZRG1 |
| 2017 | TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells2R44HG008917-02A1 | SELIGMANN, BRUCE E. | BIOSPYDER TECHNOLOGIES, INC., CA | $1,923,939 | ZRG1 |
| 2017 | Long-acting PTH for hypoparathyroidism2R44DK107231-02A1 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $1,802,798 | ZRG1 |
| 2017 | Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists2R44DK088501-04A1 | STRUTHERS, RICHARD SCOTT | CRINETICS PHARMACEUTICALS, INC., CA | $1,448,103 | ZRG1 |
| 2017 | Novel treatment of posttraumatic stress disorder2R44MH103936-03 | LAI, YVONNE Y. | ANAGIN, IN | $1,373,142 | ZRG1 |
| 2017 | Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease2R44NS084565-02 · under PA-15-269 | ACOSTA, WALTERCRAMER, CAROLE L.D'AZZO, ALESSANDRARADIN, DAVID | BIOSTRATEGIES, LC, AR | $1,366,586 | ZRG1 |
| 2017 | Unpinning Termination Therapy for Ventricular Tachyarrhythmias2R44HL107055-02 | COOPER, DANIEL HEFIMOV, IGOR RSHELTON, MICHAEL BRENT | CARDIALEN, INC., MO | $1,351,728 | ZRG1 |
| 2017 | TempO-Seq: A Multiplexed Gene Expression Profiling Platform2R44HG007339-03 · under PA-15-269 | YEAKLEY, JOANNE MULLIGAN | BIOSPYDER TECHNOLOGIES, INC., CA | $1,258,482 | ZRG1 |
| 2017 | Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery2R44CA192569-02 | KULARATNE, SUMITH | ON TARGET LABORATORIES, LLC, IL | $1,250,146 | ZRG1 |
| 2017 | Improving MPS I ERT Efficacy through Lectin-Mediated Delivery1R44NS102086-01 | ACOSTA, WALTERCRAMER, CAROLE L.RADIN, DAVID | BIOSTRATEGIES, LC, AR | $1,237,037 | ZRG1 |
| 2017 | Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent2R44CA180745-02 | KAHL, STEPHEN B | MANZANITA PHARMACEUTICALS, INC., CA | $1,220,153 | ZRG1 |
| 2017 | An optimized NK2R agonist for 'on-demand' voiding2R44AG055169-02 | THOR, KARL B | DIGNIFY THERAPEUTICS, LLC, NC | $1,158,181 | ZRG1 |
| 2017 | Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies2R44CA162629-02A1 | SERRERO, GINETTE | A AND G PHARMACEUTICAL, INC., MD | $1,154,726 | ZRG1 |
| 2017 | Safety and Efficacy Testing of FX101 in an SIV/NHP Model2R44MH096663-03A1 · under PA-15-269 | BOLTON, DIANE L.KAY, HEIDI ARAPPAPORT, JAY | JERICHO SCIENCES, LLC, VA | $1,154,643 | ZRG1 |
| 2017 | Digital serology panel for multiplex tick-borne disease testing2R44GM119873-02 | DAUGHERTY, PATRICK S | SERIMMUNE, INC., CA | $1,146,287 | ZRG1 |
| 2017 | Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II2R44CA203166-02 | ZINNEN, SHAWN PATRICK | MBC PHARMA, INC., CO | $1,138,475 | ZRG1 |
| 2017 | Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS2R44GM116211-02 | GRABAN, ERIC | RECLAIM PHARMACEUTICAL WASTE MANAGEMENT, FL | $1,100,964 | ZRG1 |
| 2017 | Improving safety and efficacy of platelet transfusion through systems biology2R44HL127843-02 | BORDBAR, AARASH | SINOPIA BIOSCIENCES, INC., CA | $1,099,022 | ZRG1 |
| 2017 | Practical high resolution microscopy of un-cut, un-embedded lung biopsies2R44CA189522-02 | LEVENE, MICHAEL JOHNTORRES, RICHARD | APPLIKATE TECHNOLOGIES, INC., CT | $1,091,279 | ZRG1 |
| 2017 | Development of a mobile and automated platform for multiplexed multi-modality imaging2R44CA192482-02A1 | GESSNER, RYAN | SONOVOL, INC., NC | $1,083,219 | ZRG1 |
| 2017 | Point of Care Breath Test to Screen for Sickle Cell Disease in Developing Nations2R44HL126469-02A1 | BHATNAGAR, ANISH | SOLENO THERAPEUTICS, INC., CA | $1,057,282 | ZRG1 |
| 2017 | Development of PAR2 Pepducins as a Novel NASH Treatment2R44DK101240-04A1 | KULIOPULOS, ATHAN | OASIS PHARMACEUTICALS, MA | $1,048,644 | ZRG1 |
| 2017 | Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen2R44CA189549-02A1 | GARLAND, WILLIAM A.THOMAS, JEFFREY H | TOSK, INC., CA | $1,043,722 | ZRG1 |
| 2017 | A novel immunotolerizing therapy for autoimmune vitiligo2R44AR065886-02A1 | MURTHY, KANNEGANTI | RADIKAL THERAPEUTICS, INC., MA | $1,039,086 | ZRG1 |
| 2017 | Phase II: Research and Commercialization of TruT Algorithm for Free Testosterone2R44AG045011-02 | JASUJA, RAVI | FUNCTION PROMOTING THERAPIES, LLC, MA | $1,029,716 | ZRG1 |
| 2017 | Novel targeted Chemotherapeutics for Gliobastoma2R44CA174129-02A1 | KOLLER, KERRY JEAN | QUADRIGA BIOSCIENCES, INC., CA | $1,018,590 | ZRG1 |
| 2017 | FrostBite - A Unique Catheter for Endoscopic Cryoablation2R44CA183265-02A1 | BAUST, JOHN M | CELL PRESERVATION SERVICES, INC., NY | $1,008,442 | ZRG1 |
| 2017 | A sample-to-answer diagnostic for neonatal bloodstream infections2R44HD083971-02 | SINGER, ALON | HELIXBIND, INC., MA | $1,003,051 | ZRG1 |
| 2017 | A Novel Peptide Therapeutic for Obesity2R44DK101197-02 | FANGER, NEIL A | VIRTICI, LLC, WA | $1,000,985 | ZRG1 |
| 2017 | Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer.2R44CA199826-02A1 | LI, YAJUAN | MOLECULAR THERANOSTICS, LLC, OH | $1,000,342 | ZRG1 |
| 2017 | Production Technology for Recombinant Intravenous Immunoglobulin2R44AI115892-02A1 · under PA-15-269 | JOHNSON, DAVID SCOTT | GIGAGEN, INC., CA | $1,000,000 | ZRG1 |
Showing the 200 most recent of 2,800 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.